{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:05:03Z","timestamp":1789625103638,"version":"build-2803163510"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Nanjing Science and technology Development Project","award":["YKK20189"],"award-info":[{"award-number":["YKK20189"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,21]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Acute necrotizing encephalopathy (ANE) is a rare but life-threatening parainfectious encephalopathy characterized by rapid neurological deterioration following viral infections. Although most cases occur sporadically, familial clustering is uncommon and suggests the involvement of genetic susceptibility factors. The emergence of coronavirus disease 2019 (COVID-19) has broadened the spectrum of viral triggers associated with ANE; however, familial COVID-19\u2013associated ANE remains rarely reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>We retrospectively reviewed 2 siblings who developed ANE following laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in December 2022. The first patient was an 18-year-old woman who presented with seizures and progressive impairment of consciousness 2 days after COVID-19 infection. Her 24-year-old brother developed a similar neurological syndrome after SARS-CoV-2 infection, characterized by altered mental status and rapid clinical deterioration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnose:<\/jats:title>\n                    <jats:p>Brain magnetic resonance imaging (MRI) of the female patient demonstrated typical bilateral symmetrical lesions involving the thalami, basal ganglia, corpus callosum, cerebellum, and cerebral white matter. MRI of her brother revealed bilateral symmetrical lesions predominantly affecting the lenticular and caudate nuclei. Genetic analysis showed no pathogenic variants in the RANBP2 gene. After comprehensive exclusion of alternative diagnoses, including other infectious encephalitis, metabolic disorders, autoimmune encephalitis, and toxic encephalopathy, both patients were diagnosed with COVID-19\u2013associated ANE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Both patients received immunomodulatory therapy, including high-dose corticosteroids and intravenous immunoglobulin. Supportive treatments and intensive neurological monitoring were also provided according to clinical conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Following treatment, both patients achieved partial neurological recovery; however, residual neurological impairment remained during short-term follow-up. The clinical course and neuroimaging findings were consistent with previously reported characteristics of ANE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>These familial cases highlight a potential association between SARS-CoV-2 infection and the development of ANE and suggest that genetic susceptibility factors other than RANBP2 mutations may contribute to disease pathogenesis. Early recognition of neurological deterioration, prompt brain MRI evaluation, and timely initiation of immunomodulatory therapy may improve clinical outcomes. Further genetic and mechanistic studies are warranted to identify additional susceptibility genes involved in COVID-19\u2013associated ANE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050329","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:05:36Z","timestamp":1787331936000},"page":"e50329","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Familial acute necrotizing encephalopathy temporally associated with SARS-CoV-2 infection"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5350-2560","authenticated-orcid":false,"given":"Ning","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Intensive Care Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipan","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixing","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260917","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/jnnp.58.5.555","article-title":"Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions.","volume":"58","author":"Mizuguchi","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R2-20260917","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/MOP.0b013e3283402bfe","article-title":"The interplay of infection and genetics in acute necrotizing encephalopathy.","volume":"22","author":"Neilson","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"R3-20260917","doi-asserted-by":"crossref","first-page":"792578","DOI":"10.1155\/2015\/792578","article-title":"Acute necrotizing encephalopathy: an underrecognized clinicoradiologic disorder.","volume":"2015","author":"Wu","year":"2015","journal-title":"Mediators Inflamm"},{"key":"R4-20260917","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3988\/jcn.2022.0431","article-title":"Acute necrotizing encephalopathy in adult patients with COVID-19: a systematic review of case reports and case series.","volume":"19","author":"Karami","year":"2023","journal-title":"J Clin Neurol"},{"key":"R5-20260917","doi-asserted-by":"crossref","first-page":"1607682","DOI":"10.3389\/fphar.2025.1607682","article-title":"Case report: long-term clinical outcomes in RANBP2-associated acute necrotizing encephalopathy.","volume":"16","author":"Varghese","year":"2025","journal-title":"Front Pharmacol"},{"key":"R6-20260917","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1148\/radiol.2020201187","article-title":"COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features.","volume":"296","author":"Poyiadji","year":"2020","journal-title":"Radiology"},{"key":"R7-20260917","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ana.10849","article-title":"Autosomal dominant acute necrotizing encephalopathy maps to 2q12.1-2q13.","volume":"55","author":"Neilson","year":"2004","journal-title":"Ann Neurol"},{"key":"R8-20260917","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1007\/s10072-021-05518-2","article-title":"Acute necrotizing encephalopathy due to SARS-CoV-2 in a pregnant female.","volume":"42","author":"Breit","year":"2021","journal-title":"Neurol Sci"},{"key":"R9-20260917","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1111\/ene.14966","article-title":"A fatal case of COVID-19-associated acute necrotizing encephalopathy.","volume":"28","author":"Ziemele","year":"2021","journal-title":"Eur J Neurol"},{"key":"R10-20260917","doi-asserted-by":"crossref","first-page":"848582","DOI":"10.3389\/fimmu.2022.848582","article-title":"Adaptive immune responses and immunity to SARS-CoV-2.","volume":"13","author":"Primorac","year":"2022","journal-title":"Front Immunol"},{"key":"R11-20260917","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ajhg.2008.12.009","article-title":"Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclearpore, RANBP2.","volume":"84","author":"Neilson","year":"2009","journal-title":"Am J Hum Genet"},{"key":"R12-20260917","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1007\/s00415-023-11915-8","article-title":"Acute necrotizing encephalopathy associated with COVID-19: case series and systematic review.","volume":"270","author":"Geng","year":"2023","journal-title":"J Neurol"},{"key":"R13-20260917","doi-asserted-by":"crossref","first-page":"e20250101","DOI":"10.70962\/jhi.20250101","article-title":"Acute necrotizing encephalopathy associated with COVID-19 in a pediatric patient and a systematic review.","volume":"2","author":"Takeuchi","year":"2026","journal-title":"J Hum Immun"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:01:06Z","timestamp":1789624866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050329"}},"subtitle":["Two case reports and literature review"],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":13,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050329","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"2025-07-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}